RILYG
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Graham Number and P/E are not applicable to senior notes.
- N/A valuation metrics due to asset being a debt instrument
Growth rates are N/A; focus is on solvency.
- Potential for restructuring
- High probability of default given health scores
- Short-term maturity window
Historical price action suggests speculative trading rather than fundamental recovery.
- Strong 1-year price appreciation (+143.5%)
- Extreme volatility
F-Score is the primary driver for the health penalty.
- Piotroski F-Score 1/9 (Weak)
Refers to the lack of dividend strength/reliability.
- Dividend strength 0/100
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for RILYG and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
RILYG
B. Riley Financial, Inc. 5.00% Senior Notes due 2026
Primary
|
+29.7% | +64.6% | +143.5% | +31.5% | +5.4% | +0.1% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
SEC Filings
Recent regulatory filings from the SEC EDGAR database
Past News Coverage
Recent headlines mentioning RILYG from our newsroom.